Table 2.
Baseline characteristics in type 2 diabetic patients with multiple-vessel disease of coronary heart disease patients.
| Variables | 1 vessel | 2 vessels | ≥3 vessels | p value |
|---|---|---|---|---|
| N (%) | 576 (25.95%) | 656 (29.55%) | 988 (44.50%) | — |
| Age (years) | 58.67 ± 10.72 | 59.79 ± 11.21 | 59.28 ± 9.88 | 0.700 |
| Male (%) | 336 (58.3%) | 384 (58.5%) | 604 (61.1%) | 0.661 |
| BMI (kg/m2) | 26.23 ± 2.9 | 26.57 ± 3.2 | 27.54 ± 3.5 | 0.156 |
| Glucose (mmol/L) | 8.07 ± 2.32 | 7.61 ± 2.09 | 7.51 ± 2.11 | 0.095 |
| HbA1c (%) | 7.77 ± 1.47 | 7.53 ± 1.39 | 7.59 ± 1.41 | 0.212 |
| ApoB (mg/dL) | 67.65 ± 21.74 | 85.22 ± 20.72 | 101.77 ± 29.43 | <0.001 |
| ApoA1 (mg/dL) | 111.87 ± 31.49 | 115.85 ± 30.24 | 118.87 ± 26.41 | 0.071 |
| Total cholesterol (mmol/L) | 4.35 (1.62) | 4.51 (1.70) | 4.68 (1.85) | 0.037 |
| Triglycerides (mmol/L) | 1.32 (0.82) | 1.38 (0.83) | 1.30 (0.78) | 0.723 |
| HDL-C (mmol/L) | 0.89 (0.32) | 0.85 (0.30) | 0.82 (0.27) | 0.537 |
| LDL-C (mmol/L) | 2.68 (1.05) | 2.83 (1.00) | 2.99 (1.34) | 0.014 |
| Lp(a) (nmol/L) | 37.80 (40.61) | 41.51 (49.94) | 39.47 (45.54) | 0.189 |
| hs-CRP (mg/L) | 5.60 (8.03) | 4.41 (7.12) | 3.10 (6.57) | 0.002 |
| HCY (mumol/L) | 11.60 (8.14) | 12.69 (10.37) | 12.00 (11.53) | 0.078 |
| sdLDL-C (mmol/L) | 0.72 (0.24) | 0.80 (0.24) | 0.85 (0.52) | 0.003 |
Data are reported as the means ± SD or n (%), median (interquartile ranges). SD: standard deviation; BMI: body mass index; HbA1c: hemoglobin A1c; apoB: apolipoprotein B; apoA1: apolipoprotein A1; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; Lp(a): lipoprotein (a); hs-CRP: hypersensitive C-reactive protein; HCY: homocysteine; sdLDL-C: small dense low-density lipoprotein cholesterol. Statistical analysis was performed with the ANOVA or Kruskal-Wallis test and with chi-squared test for categorical variables.